SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer

(2013) Rossana Berardi et al.   OncoTargets and Therapy

Synthesis, structure–activity relationships and preliminary antitumor evaluation of benzothiazole-2-thiol derivatives as novel apoptosis inducers

(2011) Zhao Wang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: A review of existing evidence

(2011) S. Novello et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Comparative Proteomic Approach Identifies Pkm2 and Cofilin-1 as Potential Diagnostic, Prognostic and Therapeutic Targets for Pulmonary Adenocarcinoma

(2011) Xing-chen Peng et al.   PLoS One

Synthesis and anti-cancer activity of benzothiazole containing phthalimide on human carcinoma cell lines

(2008) Stanton Hon Lung Kok et al.   BIOORGANIC & MEDICINAL CHEMISTRY

The RhoGDI-α/JNK signaling pathway plays a significant role in mycophenolic acid-induced apoptosis in an insulin-secreting cell line

(2008) Yun-Jong Park et al.   CELLULAR SIGNALLING

Overexpression of Rho GDP-Dissociation Inhibitor Alpha Is Associated with Tumor Progression and Poor Prognosis of Colorectal Cancer

(2008) Liang Zhao et al.   JOURNAL OF PROTEOME RESEARCH

Synthesis of amide and urea derivatives of benzothiazole as Raf-1 inhibitor

(2007) Eun Young Song et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY